195 related articles for article (PubMed ID: 33167557)
1. The Effect of the Dose of Isotonic Saline on the Correction of Serum Sodium in the Treatment of Hypovolemic Hyponatremia.
Ruiz-Sánchez JG; Meneses D; Álvarez-Escolá C; Cuesta M; Calle-Pascual AL; Runkle I
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33167557
[TBL] [Abstract][Full Text] [Related]
2. A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.
Aratani S; Hara M; Nagahama M; Taki F; Futatsuyama M; Tsuruoka S; Komatsu Y
BMC Nephrol; 2017 Oct; 18(1):316. PubMed ID: 29047375
[TBL] [Abstract][Full Text] [Related]
3. The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.
Ward FL; Tobe SW; Naimark DMJ
Can J Kidney Health Dis; 2018; 5():2054358118761051. PubMed ID: 29593879
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Kim Y; Lee N; Lee KE; Gwak HS
Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
[TBL] [Abstract][Full Text] [Related]
5. Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.
Baek SH; Jo YH; Ahn S; Medina-Liabres K; Oh YK; Lee JB; Kim S
JAMA Intern Med; 2021 Jan; 181(1):81-92. PubMed ID: 33104189
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate therapy of euvolemic hyponatremia, the most frequent type of hyponatremia in SARS-CoV-2 infection, is associated with increased mortality in COVID-19 patients.
Pazos-Guerra M; Ruiz-Sánchez JG; Pérez-Candel X; López-Nevado C; Hernández-Olmeda F; Cuesta-Hernández M; Martín-Sánchez J; Calle-Pascual AL; Runkle-de la Vega I
Front Endocrinol (Lausanne); 2023; 14():1227059. PubMed ID: 37560297
[TBL] [Abstract][Full Text] [Related]
7. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
[TBL] [Abstract][Full Text] [Related]
8. Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Pelouto A; Refardt JC; Christ-Crain M; Zandbergen AAM; Hoorn EJ
Eur J Endocrinol; 2023 Mar; 188(3):322-330. PubMed ID: 36881992
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of overcorrection in patients presenting with severe hyponatremia to the emergency department.
Sumi H; Imai N; Shibagaki Y
Clin Exp Nephrol; 2022 Nov; 26(11):1086-1091. PubMed ID: 35870090
[TBL] [Abstract][Full Text] [Related]
10. NaCl 3% Bolus Therapy as Emergency Treatment for Severe Hyponatremia: Comparison of 100 mL vs 250 mL.
Massop K; Haverkort DA; Bech AP; de Boer H
J Clin Endocrinol Metab; 2023 Jul; 108(8):e521-e526. PubMed ID: 36808420
[TBL] [Abstract][Full Text] [Related]
11. Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting.
Chatzimavridou-Grigoriadou V; Al-Othman S; Brabant G; Kyriacou A; King J; Blackhall F; Trainer PJ; Higham CE
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4766-e4775. PubMed ID: 33693944
[TBL] [Abstract][Full Text] [Related]
12. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
13. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
Woodfine JD; Sood MM; MacMillan TE; Cavalcanti RB; van Walraven C
Clin J Am Soc Nephrol; 2019 Jul; 14(7):975-982. PubMed ID: 31189541
[TBL] [Abstract][Full Text] [Related]
14. Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: A retrospective, propensity score-based, single-center cohort study.
Jingushi N; Tsuzuki S; Fujii K; Uenishi N; Iwata M; Terasawa T
J Crit Care; 2021 Aug; 64():53-61. PubMed ID: 33794467
[TBL] [Abstract][Full Text] [Related]
15. Treatment of symptomatic hyponatremia.
Decaux G; Soupart A
Am J Med Sci; 2003 Jul; 326(1):25-30. PubMed ID: 12861122
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the incidences of hyponatremia in adult postoperative critically ill patients receiving intravenous maintenance fluids with 140 mmol/L or 35 mmol/L of sodium: retrospective before/after observational study.
Okada M; Egi M; Yokota Y; Shirakawa N; Fujimoto D; Taguchi S; Furushima N; Mizobuchi S
J Anesth; 2017 Oct; 31(5):657-663. PubMed ID: 28455602
[TBL] [Abstract][Full Text] [Related]
17. Criteria for Hyponatremic Overcorrection: Systematic Review and Cohort Study of Emergently Ill Patients.
Woodfine JD; van Walraven C
J Gen Intern Med; 2020 Jan; 35(1):315-321. PubMed ID: 31452039
[TBL] [Abstract][Full Text] [Related]
18. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM
Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871
[TBL] [Abstract][Full Text] [Related]
19. Osmotic Demyelination Syndrome following Correction of Hyponatremia by ≤10 mEq/L per Day.
Tandukar S; Sterns RH; Rondon-Berrios H
Kidney360; 2021 Sep; 2(9):1415-1423. PubMed ID: 35373113
[TBL] [Abstract][Full Text] [Related]
20. The treatment of hyponatremia.
Sterns RH; Nigwekar SU; Hix JK
Semin Nephrol; 2009 May; 29(3):282-99. PubMed ID: 19523575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
